Abstract

Current cancer treatments often involve administering drugs that spread throughout the entire body. Not only does merely a tiny fraction of the drugs generally reach the target area but healthy cells and organs often end up damaged, leading to the many side effects that have been observed. Magnetic guidance constitutes an effective solution to the problem. By guiding drugs through the vascular system from an injection site towards a tumour, the technique promises to significantly increase the efficacy of the treatments and minimize their secondary toxicity. The method developed by Maxime Latulippe - dipole field navigation (DFN) - overcomes the limitations of current magnetic guidance methods.